We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
AusPAR: Pembrolizumab (rch)
Australian Public Assessment Report
Device/Product Name
Keytruda
Active ingredients
Pembrolizumab (rch)
AusPAR Date
Published
Submission Number
PM-2019-02526-1-4
Submission Type
Extension of indications
Decision
Approved